SNHG4 and neoplasm: The present data showed that RUNX2, a well-known transcription factor that participated in tumor EMT, migration, and invasion [35, 36], was recognized as the downstream target of miR-204-5p and had a competition with SNHG4 to interact with miR-204-5p in RCC cell lines.